" class="no-js "lang="en-US">  James A. Grifo - Medtech Alert
Friday, March 31, 2023

Breaking News

Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Hansa Biopharma Completes Enrollment in Phase 2 Study of Imlifidase in Guillain-Barré Syndrome (GBS) ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment NADclinic Group, BioStarks and Do Not Age Announce Exclusive Partnership to Revolutionise Personalised Longevity PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa
James A. Grifo

 James A. Grifo

About  James A. Grifo

Jamie Grifo has been the Program Director of the New York University (NYU) Langone Fertility Center since 1995. He is also the Director of the Division of Reproductive Endocrinology and a Professor of Obstetrics and Gynecology at the NYU School of Medicine.

Related Story

Companies

 Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform | Pharmtech Focus

Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform

July 27 2022

Rona Therapeutics, Inc (“Rona”), a fully integrated platform company dedicated to the discovery, development and […]

Resources

 Frozen Eggs More Efficient Option than IVF for Women Starting Families Later | Pharmtech Focus

Frozen Eggs More Efficient Option than IVF for Women Starting Families Later

May 27 2022

The largest U.S. report of elective fertility preservation outcomes to date found that 70 percent […]